Alfaro, Merlyn D.
HRN: 01-24-35 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
07/09/2026
07/15/2026
IV
750mg LDA Then 500mg Iv Q48H
Q48
Cap Mr
Checking Initial Appropriateness
07/15/2026
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
07/15/2026
07/21/2026
TOPICAL
1%
BID
Decubitus Ulcer
Checking Final Appropriateness